AMGEN HIGHLIGHTS HEMATOLOGY PORTFOLIO AT ASH 2023 Read more about AMGEN HIGHLIGHTS HEMATOLOGY PORTFOLIO AT ASH 2023
AMGEN TO PRESENT AT THE EVERCORE ISI HEALTHCONX CONFERENCE Read more about AMGEN TO PRESENT AT THE EVERCORE ISI HEALTHCONX CONFERENCE
AMGEN PRESENTS NEW CARDIOVASCULAR RESEARCH AT AHA 2023 Read more about AMGEN PRESENTS NEW CARDIOVASCULAR RESEARCH AT AHA 2023
AMGEN PRESENTS NEW RESEARCH IN EARLY PSORIATIC ARTHRITIS AT ACR 2023 Read more about AMGEN PRESENTS NEW RESEARCH IN EARLY PSORIATIC ARTHRITIS AT ACR 2023
AMGEN PRESENTS NEW DATA FROM PHASE 2 TRIAL OF DAZODALIBEP IN SJÖGREN'S SYNDROME AT ACR 2023 Read more about AMGEN PRESENTS NEW DATA FROM PHASE 2 TRIAL OF DAZODALIBEP IN SJÖGREN'S SYNDROME AT ACR 2023
AMGEN PRESENTS NEW DATA THAT SHOW BLOOD PRESSURE DECREASES FOR ADULTS TREATED WITH KRYSTEXXA® (PEGLOTICASE) Read more about AMGEN PRESENTS NEW DATA THAT SHOW BLOOD PRESSURE DECREASES FOR ADULTS TREATED WITH KRYSTEXXA® (PEGLOTICASE)
AMGEN TO PRESENT DATA AT ACR 2023 ACROSS EXPANDED RHEUMATOLOGY PIPELINE AND PORTFOLIO Read more about AMGEN TO PRESENT DATA AT ACR 2023 ACROSS EXPANDED RHEUMATOLOGY PIPELINE AND PORTFOLIO
AMGEN REPORTS THIRD QUARTER FINANCIAL RESULTS Read more about AMGEN REPORTS THIRD QUARTER FINANCIAL RESULTS
AMGEN ANNOUNCES WEBCAST OF 2023 THIRD QUARTER FINANCIAL RESULTS Read more about AMGEN ANNOUNCES WEBCAST OF 2023 THIRD QUARTER FINANCIAL RESULTS
